Ann Marie Rogers won a landmark victory to make the breast cancer drug Herceptin more widely available ... carefully because they're part of legal history, but I'm not interested in that.

While the pembrolizumab copy was eye-catching, the firm’s next big biosimilar launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to launch ...

The mode of action of Herceptin activates the body's immune system and suppresses HER2 signalling to target and destroy the tumour. The drug was first approved in 1998 and has been used to treat ...

The new Herceptin formulation is now in phase 3 clinical trials, and if the program were successful, it would offer patients a convenient dosing form of the drug, which is currently given via ...